GSK plc (GSK) DCF Valuation

GSK plc (GSK) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

GSK plc (GSK) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate GSK plc's financial prospects like an expert! This (GSK) DCF Calculator comes with pre-filled financial data and allows you full flexibility to modify revenue growth, WACC, margins, and other critical assumptions to align with your forecasts.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 42,447.7 42,881.6 42,900.4 36,876.7 38,139.3 37,228.6 36,339.7 35,471.9 34,624.9 33,798.2
Revenue Growth, % 0 1.02 0.04398956 -14.04 3.42 -2.39 -2.39 -2.39 -2.39 -2.39
EBITDA 11,790.9 12,779.3 9,753.6 10,851.5 11,491.6 10,414.4 10,165.8 9,923.0 9,686.1 9,454.8
EBITDA, % 27.78 29.8 22.74 29.43 30.13 27.97 27.97 27.97 27.97 27.97
Depreciation 2,935.1 2,956.5 2,668.5 2,700.0 2,884.8 2,599.7 2,537.6 2,477.0 2,417.9 2,360.1
Depreciation, % 6.91 6.89 6.22 7.32 7.56 6.98 6.98 6.98 6.98 6.98
EBIT 8,855.7 9,822.8 7,085.1 8,151.5 8,606.7 7,814.7 7,628.1 7,446.0 7,268.2 7,094.6
EBIT, % 20.86 22.91 16.52 22.1 22.57 20.99 20.99 20.99 20.99 20.99
Total Cash 6,018.7 8,010.7 5,451.5 9,905.8 6,277.7 6,618.5 6,460.4 6,306.2 6,155.6 6,008.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 6,900.2 6,978.2 7,854.7 6,856.2 7,425.9
Account Receivables, % 16.26 16.27 18.31 18.59 19.47
Inventories 7,478.7 7,540.3 7,272.5 6,471.4 6,914.1 6,539.7 6,383.6 6,231.1 6,082.4 5,937.1
Inventories, % 17.62 17.58 16.95 17.55 18.13 17.57 17.57 17.57 17.57 17.57
Accounts Payable 5,211.3 5,479.2 5,703.0 4,861.7 4,674.4 4,749.5 4,636.1 4,525.4 4,417.3 4,311.8
Accounts Payable, % 12.28 12.78 13.29 13.18 12.26 12.76 12.76 12.76 12.76 12.76
Capital Expenditure -2,720.1 -2,815.7 -3,685.9 -2,839.6 -2,947.7 -2,754.6 -2,688.8 -2,624.6 -2,561.9 -2,500.7
Capital Expenditure, % -6.41 -6.57 -8.59 -7.7 -7.73 -7.4 -7.4 -7.4 -7.4 -7.4
Tax Rate, % 18.73 18.73 18.73 18.73 18.73 18.73 18.73 18.73 18.73 18.73
EBITAT 6,612.3 8,104.4 5,709.0 7,127.5 6,994.4 6,352.7 6,201.0 6,052.9 5,908.4 5,767.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2,340.3 8,373.5 4,306.8 7,946.2 5,731.8 7,453.8 6,250.6 6,101.4 5,955.7 5,813.5
WACC, % 5.63 5.68 5.67 5.71 5.67 5.67 5.67 5.67 5.67 5.67
PV UFCF
SUM PV UFCF 27,008.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 5,930
Terminal Value 161,360
Present Terminal Value 122,444
Enterprise Value 149,452
Net Debt 19,205
Equity Value 130,247
Diluted Shares Outstanding, MM 4,111
Equity Value Per Share 31.68

What You Will Get

  • Real GSK Financial Data: Pre-filled with GSK’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See GSK’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive GSK Financials: Gain access to precise pre-loaded historical data and forward-looking projections.
  • Adjustable Forecast Parameters: Modify highlighted cells for metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow analysis.
  • Interactive Dashboard: User-friendly charts and summaries to help visualize your valuation insights.
  • Designed for All Users: An intuitive layout tailored for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered GSK data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for GSK’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose GSK plc (GSK)?

  • Innovative Research: GSK is at the forefront of scientific advancements in healthcare.
  • Commitment to Quality: High standards in manufacturing ensure the safety and efficacy of products.
  • Global Reach: GSK operates in numerous countries, providing access to vital medications worldwide.
  • Patient-Centric Approach: Focused on improving patient outcomes through tailored healthcare solutions.
  • Expertise in Biopharmaceuticals: Renowned for cutting-edge treatments and therapies in various therapeutic areas.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and trustworthy valuation models for portfolio assessment related to GSK plc (GSK).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform internal strategic decisions for GSK plc (GSK).
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in GSK plc (GSK).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling with GSK plc (GSK).
  • Healthcare Enthusiasts: Gain insights into how pharmaceutical companies like GSK plc (GSK) are valued within the market.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations.
  • Real-World Data: GSK plc’s (GSK) historical and projected financials preloaded for analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables providing clear, actionable results.

No products were found matching.